Grupo Mateus S.A (GMAT3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 5.300 |
|---|---|
| 52-week range | 3.430 – 6.640 |
| Return, 1 month / 3 months | +8.2% / +37.0% |
| Return, 1 year / 3 years | −14.8% / −9.2% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 43.2% |
| Worst drawdown (1 year) | -45.2% |
| Average daily value traded | 30.27M BRL |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Grupo Mateus is a Brazilian food retailer based in São Luís, in the state of Maranhão. It runs supermarkets, hypermarkets and cash-and-carry wholesale stores, serving everyday shoppers as well as small retailers and businesses that buy in bulk. The company also operates its own distribution and logistics network, which supplies its stores across the Northeast and other regions of Brazil. Its business centres on selling food, household goods and other consumer products through its retail and wholesale formats.
On this site Grupo Mateus S.A appears as a stock on the Sao Paulo Exchange (Brazil), code GMAT3, with prices in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Grupo Mateus S.A (GMAT3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 5.300 on 23 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 621 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.8% and over the last three months it rose 37.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 16.7% | ||
| From 52-week high | -19.3% | ||
| Momentum | 62 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 37.0% | ||
| 6-month return | 17.3% | ||
| 12-month return, skipping the last month | -21.2% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.2% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 30.27M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 7 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | +8.2% |
| 3 months | +37.0% |
| 6 months | +17.3% |
| 1 year | −14.8% |
| 3 years | −9.2% |
| 5 years | −26.4% |
Signals
| 50-day / 200-day average | 4.717 / 4.541 |
|---|---|
| Golden / death cross (60 days) | Golden, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.243 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Nov 2025 | BRL 0.0496 |
| 25 Sep 2025 | BRL 0.0694 |
| 26 Jun 2025 | BRL 0.0671 |
| 26 Mar 2025 | BRL 0.0601 |
| 11 Nov 2024 | BRL 0.0436 |
| 26 Sep 2024 | BRL 0.0455 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.